What is the appropriate diagnosis and management for congenital glucose‑galactose malabsorption?

Diagnosis and Management of Congenital Glucose-Galactose Malabsorption

Congenital glucose-galactose malabsorption (CGGM) requires immediate dietary elimination of glucose and galactose with fructose-based formula, which results in complete resolution of diarrhea and excellent prognosis when diagnosed early.

Clinical Presentation and Diagnosis

Key Clinical Features to Recognize

CGGM presents as severe, watery, acidic diarrhea beginning within the first days of life, accompanied by:

• Hypertonic (hypernatremic) dehydration - this is a hallmark feature that should raise suspicion 1, 2
• Severe dehydration despite fluid replacement
• Weight loss and failure to thrive
• Abdominal distension (50% of cases) 2
• Vomiting (approximately 10% of cases)
• Hypercalcemia and nephrolithiasis/nephrocalcinosis (18.7% of cases) 2, 3

Critical diagnostic clue: The diarrhea stops completely with fasting and resumes immediately when feeding is reintroduced 4.

Diagnostic Approach

The diagnosis is often delayed - 51.4% of cases are diagnosed more than 1 month after symptom onset 2, which is unacceptable given the life-threatening nature and simple treatment.

Immediate bedside diagnostic steps:

1. Stool pH testing - typically acidic (pH < 6.0) due to unabsorbed carbohydrates 2
2. Stool reducing substances - positive (>0.5%), though this alone is not diagnostic 5
3. Fasting trial - complete cessation of diarrhea with fasting is highly suggestive 4

Confirmatory testing:

• Genetic testing (SLC5A1 gene sequencing) - this is the gold standard and should be performed in all suspected cases 1, 3, 2. Approximately 68% of reported cases have undergone genetic testing, revealing 30 different SLC5A1 mutations 2
• Oral glucose tolerance test (OGTT) - shows abnormal curve with glucose but normal curve with fructose 4
• Hydrogen breath test - positive with glucose/galactose challenge 4

Important caveat: The presence of stool reducing substances with increased stool output during oral rehydration solution (ORS) administration indicates true glucose malabsorption, not just the presence of reducing substances alone 5. Patients with true glucose malabsorption show immediate reduction in stool output when IV therapy replaces oral therapy 5.

High-Risk Populations

Consanguineous marriage is a major risk factor - 78.2% of cases from Saudi Arabia and Turkey involved consanguineous parents 2. Always inquire about family history and consanguinity.

Management

Acute Phase Management

For severe dehydration/shock:

• IV rehydration initially - patients in shock or near-shock require IV fluids first 5
• Once stabilized, transition to appropriate feeding

Critical management principle: Standard glucose-based oral rehydration solutions (ORS) will worsen diarrhea in CGGM due to glucose malabsorption 5. This is a common pitfall that delays diagnosis.

Definitive Dietary Management

The cornerstone of treatment is complete elimination of glucose and galactose from the diet:

1. Fructose-based formula - this is the definitive treatment 1, 3, 2, 6, 4

   • Results in immediate resolution of diarrhea (typically within 24-48 hours)
   • Allows normal growth and development
   • 97.2% of cases recover with fructose formula 2

2. Alternative formulas if fructose-based unavailable:

   • Ketogenic formula can be used temporarily 3
   • Avoid: lactose-containing formulas, glucose-containing formulas, amino acid-based formulas, extensively hydrolyzed formulas, rice-based formulas - all have failed in documented cases 3

Long-Term Management

As the child grows:

• Transition to low-carbohydrate diet with careful introduction of fructose-containing foods 6
• Avoid all glucose and galactose sources (including lactose, which contains galactose)
• Long-term nutritional guidance is essential - requires ongoing support from pediatric nutritionists and dietitians 6
• Monitor growth parameters closely

Prognosis

Excellent prognosis with appropriate dietary management:

• Normal growth and development when glucose/galactose eliminated 4
• Mortality is rare (1.9%) when diagnosed and treated appropriately 2
• Complications occur primarily from delayed diagnosis

Critical Pitfalls to Avoid

1. Attempting multiple formula trials without considering CGGM - this delays diagnosis and worsens outcomes 3

2. Using standard glucose-based ORS - this exacerbates diarrhea in CGGM patients 5

3. Misinterpreting stool reducing substances - their presence alone doesn't confirm malabsorption; clinical correlation with increased stool output during feeding is required 5

4. Delayed genetic testing - should be performed early in any infant with persistent diarrhea and hypernatremic dehydration 1

5. Inadequate long-term follow-up - these patients require lifelong dietary management and nutritional monitoring 6

Genetic Counseling

Given the autosomal recessive inheritance pattern, genetic counseling for affected families is essential 3. Siblings have a 25% recurrence risk, and prenatal diagnosis is possible with known familial mutations.